3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
21
Carcinoma, Non-Small-Cell Lung
12
Rectal Neoplasms
9
Glioblastoma
9
Esophageal Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Lung Neoplasms
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
5
Sarcoma
4
Ovarian Neoplasms
4
Neoplasms
4
Fallopian Tube Neoplasms
4
Colonic Neoplasms
3
Brain Neoplasms
3
Adenocarcinoma of Lung
3
Urinary Bladder Neoplasms
2
Osteosarcoma
2
Melanoma
2
Glioma
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma
2
Adenocarcinoma Of Esophagus
2
Xerostomia
1
Wilms Tumor
1
Urethral Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
vandetanib
9
cabozantinib
6
selpercatinib
4
Sorafenib
3
Sunitinib
2
Magnetic Resonance Spectroscopy
2
yeast-CEA vaccine
1
tanespimycin
1
rovalpituzumab tesirine
1
pralsetinib
1
pembrolizumab
1
pazopanib
1
lenvatinib
1
Vorinostat
1
Temozolomide
1
Specimen Handling
1
Pharmacogenomic Testing
1
Nivolumab
1
Lithium Carbonate
1
Irinotecan
1
Gefitinib
1
Ferrosoferric Oxide
1
Dexamethasone
1
Capecitabine
1
Bortezomib
1
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Medullary
×
Surgical Procedures, Operative
×
Clear all
No trials found.